ThomasNet News Logo
Sign Up | Log In | ThomasNet Home | Promote Your Business

Dilon Receives CE Mark Approval for Its Navigator Gamma Probe System

Print | 
Email |  Comment   Share  

Dilon Technologies
12050 Jefferson Avenue
Newport News, VA, 23606

Press release date: July 10, 2014

NEWPORT NEWS, Va. — Dilon Technologies, leader in molecular imaging cameras including Molecular Breast Imaging (MBI/BSGI), announced today that it obtained CE Mark approval for its Navigator® Gamma Probe system. The CE Mark allows Dilon to begin marketing the device throughout the European Union. Dilon has expanded its distribution into the majority of European countries and has already received the first orders.

"The Navigator Gamma Probe has been strongly accepted by surgeons in the United States. Three major influences for surgeon acceptance has been the strong reliability, simple design and ease of operation" stated Robert Moussa, Dilon's President and CEO. "A comparable market response is anticipated for Europe and other countries around the world that recognize the CE Mark."

The Navigator Gamma Probe system is used in radio-guided surgical procedures, primarily for lymphatic mapping and tumor localization. Over the last several decades, procedures such as sentinel lymph node mapping, first in melanoma, and more recently in breast, have become a gold standard of care among general surgeons and surgical oncologists. Additional applications for the Navigator Gamma Probes are in pulmonary wedge resection, parathyroid adenoma, and laparoscopy.

About Dilon
Dilon Technologies® Inc. strives to improve the quality of life by providing a wide range of innovative medical solutions that benefit patients around the world. Dilon is a leader in diagnostic imaging with the Dilon Molecular Imaging Systems, high-resolution, small field-of-view general-use molecular imaging cameras, optimized to perform Molecular Breast Imaging (MBI/BSGI) and localization for MBI-guided breast biopsy. Dilon's cornerstone surgical imaging products, the Navigator® Probes, are one of the most widely used gamma probes for cancer surgery in the marketplace. The gamma probes offer a revolutionary upgrade option for 3D Tumor Imaging and Navigation with SurgicEye's declipseSPECT camera. Dilon is the exclusive international distributor of Digirad's Cardius® cardiac and ergo™ general molecular imaging cameras that provide outstanding image quality and increased patient comfort with a compact, open design. For more information visit

Media contact:
Pjerin Luli
P: 757-269-4910

SOURCE Dilon Technologies Inc.
Print | 
Email |  Comment   Share  
Contacts: View detailed contact information.


Post a comment about this story

(your e-mail address will not be posted)
Comment title:
To submit comment, enter the security code shown below and press 'Post Comment'.

 See related product stories
More .....
 See more product news in:
Health, Medical and Dental Supplies and Equipment
Vision Systems
| Featured Manufacturing Jobs
 Other News from this company:
Dilon Technologies Announces a Transportable Version of the Dilon 6800 Gamma Camera
Increased Demand for Adjunctive Imaging for Breast Cancer Results in Dramatic Gamma Camera Sales Surge at Dilon Technologies
More ....
 Tools for you
Watch Company 
View Company Profile
Company web site
More news from this company
E-mail this story to a friend
Save Story
Search for suppliers of
Medical Probes
Gamma Cameras
Medical Imaging Systems
Join the forum discussion at:
Tools of the Trade
Wired In

Home  |  My ThomasNet News®  |  Industry Market Trends®  |  Submit Release  |  Advertise  |  Contact News  |  About Us
Brought to you by        Browse ThomasNet Directory

Copyright © 2014 Thomas Publishing Company. All Rights Reserved.
Terms of Use - Privacy Policy

Error close

Please enter a valid email address